AAA
AZN icon

Affinity Asset Advisors’s AstraZeneca AZN Stock Holding History

Affinity Asset Advisors’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-50,000
Closed -$5.48M – 65
2022
Q3 		$5.48M Buy
+50,000
New +$6.34M 1.53% 18

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Affinity Asset Advisors's AZN Position: Q1 2024 in Review

Affinity Asset Advisors sold out of AstraZeneca (AZN) in Q1 2024, closing a stake of 30,000 shares — an estimated $4.04M sold.

Affinity Asset Advisors first reported a position in AZN in Q1 2022 and held it in 8 quarters. The position peaked at $10.6M in Q1 2022. 1,141 funds tracked by Wall St. Rank hold AZN as of Q1 2024.

  • Affinity Asset Advisors reported no remaining AstraZeneca position as of Q1 2024 after selling out during the quarter.
  • Affinity Asset Advisors sold 30,000 AstraZeneca shares in Q1 2024, an estimated $4.04M.
  • Affinity Asset Advisors first reported a position in AstraZeneca in Q1 2022 and held it in 8 quarters.
  • Affinity Asset Advisors's AstraZeneca position peaked at $10.6M in Q1 2022.
  • 1,141 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2024.

Based on Affinity Asset Advisors's 13F filing for Q1 2024, filed 14 May 2024.